Key result
Nifedipine treatment partially reversed or prevented the aging-associated shift in cardiac myosin isozymes and reduced left ventricular to body weight ratio by 18% in hypertensive rats.
Why the study?
Does nifedipine modulate cardiac myosin isozyme proportions in aging and chronically hypertensive rats?
Does nifedipine modulate cardiac myosin isozyme proportions in aging and chronically hypertensive rats?
Answers are grounded in this paper and cite their sources.
Nifedipine partially reverses or prevents the aging-associated shift in cardiac myosin isozymes in rats, independent of its effect on left ventricular hypertrophy.
OBJECTIVE: Pressure induced left ventricular hypertrophy is associated with alterations in distribution of cardiac myosin isozymes. This study evaluated the influence of aging, superimposed chronic hypertension on aging, and treatment with nifedipine on cardiac myosin isozyme proportions. METHODS: Myosin isozyme (V1, V2, and V3) proportions were investigated by pyrophosphate gel electrophoresis, and left ventricular to body weight ratio was studied in two subgroups each of hypertensive and normotensive rats, with and without nifedipine treatment. Nifedipine treatment was started at 48 weeks and concluded at 60 weeks. RESULTS: For all four groups, the V1 level was the lowest (range 15%-24%), V3 was the highest (47%-60%), and V2 was intermediate (25%-29%). The left ventricular weight to body weight ratio was 25% higher (p < 0.001) in the untreated old hypertensive v old rats, but V1 level was of the same magnitude in both these groups. The left ventricular weight to body weight ratio was 18% lower (p < 0.001) in the old hypertensive treated v untreated rats. The V1 level was higher in both treated groups; old normotensive as well as old hypertensive rats. The changes in V1 were not statistically correlated with arterial pressure and left ventricular to body weight ratio. CONCLUSIONS: The profound decrease in V1 myosin isozyme proportion acquired with aging is not accentuated by superimposed chronic hypertension. The aging process, and not the left ventricular hypertrophy by itself, seems to be the principal determinant of the myosin isozyme shift. The myosin isozyme shift that occurs with aging is not fixed, and can be partially reversed or prevented by nifedipine.
No takes yet. Share an insight, caveat, or question.
Raizada et al. (1993) studied Hypertension and aging. Nifedipine vs. Untreated was evaluated on Left ventricular weight to body weight ratio and myosin isozyme proportions (p=<0.001). Nifedipine treatment partially reversed or prevented the aging-associated shift in cardiac myosin isozymes and reduced left ventricular to body weight ratio by 18% in hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: